Bullish option flow detected in Iovance Biotherapeutics with 3,884 calls trading, 1.1x expected, and implied vol increasing almost 9 points to 79.28%. Oct-24 11 calls and Jan-25 10 calls are the most active options, with total volume in those strikes near 2,900 contracts. The Put/Call Ratio is 0.19. Earnings are expected on November 5th.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IOVA:
- Iovance Biotherapeutics call volume above normal and directionally bullish
- Iovance Biotherapeutics to Present at Upcoming Conferences
- Iovance Biotherapeutics put volume heavy and directionally bearish
- Iovance Biotherapeutics ‘pretty attractive long idea,’ says Martin Shkreli
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)